Back to home
TECHNOLOGY15 July 2026
From iPhone Face ID to the Human Mind: An Apple Engineer’s Quest for a Low‑Cost AI Brain Scan
Apple’s former Face ID lead has launched Hemispheric, a startup that uses AI to turn routine brain scans into cheap, rapid diagnostics for depression, PTSD and Parkinson’s. The technology aims to match the accessibility of a blood test, potentially reshaping mental‑health screening.
La
La Rédaction
The Vertex
5 min read

Source: www.wired.com
Gidi Littwin, the engineer behind Apple’s Face ID, has turned his attention from facial recognition to the human brain. After a decade at the forefront of biometric security, he founded Hemispheric, a startup dedicated to translating his AI expertise into affordable diagnostics for neurological and psychiatric disorders. His move reflects a growing belief that the same algorithms that unlock a phone’s security can also unlock insights into the mind’s hidden states.
The platform uses magnetic resonance imaging combined with deep‑learning algorithms to generate a quantitative profile of brain activity, flagging patterns associated with depression, PTSD and Parkinson’s disease. The model is trained on thousands of annotated scans, allowing it to detect subtle atrophy or connectivity changes that precede clinical symptoms. By converting raw scan data into a compact, interpretable score, the system promises to deliver results in minutes rather than weeks, mirroring the speed of a routine blood test.
Placing AI‑driven brain diagnostics on the same cost curve as a simple blood panel could democratize mental‑health screening, especially in low‑resource settings where specialist care is scarce. Yet the technology must overcome hurdles such as data privacy, regulatory approval, and the need for robust validation across diverse populations before it can be widely adopted.
If Hemispheric succeeds, the ripple effects could reshape how clinicians monitor disease progression, enable earlier interventions, and perhaps even personalize therapeutic regimens based on real‑time neural metrics. The venture underscores a broader industry shift toward point‑of‑care AI, where the line between consumer tech and medical device blurs, heralding a future where the brain’s health is as routinely assessed as its outward appearance.